Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
deals
national top stories
san francisco blog main
startups
boston
clinical trials
health
new york blog main
new york top stories
san francisco top stories
third rock ventures
vc
acetylon pharmaceuticals
ally bridge group
ambys medicines
artificial intelligence
azacitidine
beta-thalassemia
big data analytics
biopharmaceutical
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
business
cancer
cancer drugs
casdin capital
cell therapy
constellation pharmaceuticals
dacogen
deciphera pharmaceuticals
decitabine
diabetic nephropathy
dna
What
biotech
6
×
medicines
6
×
new
6
×
research
drug
called
companies
company
developing
diseases
drugs
formed
ipo
labs
lead
ready
startup
therapeutics
abbott
abbvie
agreement
aiming
aims
algorithms
ambys
analysis
announced
approach
backed
based
batch
big
bio
biopharma
black
bottlenecks
bring
calico
cancer
center
Language
unset
Current search:
medicines
×
biotech
×
new
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center